Novasenta

Novasenta is a biotechnology company based in Pittsburgh, Pennsylvania. The company is privately held and employs six people. Novasenta focuses on discovering novel therapeutic targets for innovative cancer treatments. They leverage a systematic and rigorous approach to analyze the human tumor microenvironment, seeking to uncover new targets exploitable for drug development. This approach considers the complex interplay of cancer, immune response, and metabolism. Novasenta utilizes single-cell level analysis of human tumor samples, enhanced by the expertise of its research and computational biology teams. Novasenta's commitment to thorough analysis and exploration of the human tumor microenvironment aims to accelerate the development of effective therapies for a variety of cancers. You can learn more about Novasenta and their work at novasenta.com.